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Abstract 
Objective: b7-H4, a member of the b7 family of im-
munoregulatory receptors, may participate in the nega-
tive  regulation  of  cell-mediated  immunity.  aberrant
b7-H4 expression is detected in some tumors and it
plays a role in the occurrence and development of tu-
mors. the aim of this study was to elucidate the func-
tional and structural properties of b7-H4.
Methods: We developed a monoclonal antibody (mab)
against the extracellular domain of b7-H4 through im-
munization  of  balb/c  mice  with  3t3-mb7-H4  cells
which expressed extrinsic b7-H4. a stable hybridoma
cell line was established. then, we analysised the char-
acterization of the mab through Enzyme linked im-
munosorbent  assay  (ElISa),  Immunoprecipitation
(IP),  western  blotting,  Immunohistochemical  (IHc),
and tested the biological activity of the mab. 
Results: ElISa, IP, and western blotting analyses indi-
cated that the mab specifically recognized b7-H4. In
addition, flow cytometry demonstrated that the mab
exhibits excellent reactivity when applied to leukemic
cells. IHc staining revealed that the mab stained in a
predominantly  diffuse  plasmalemmal  or  cytoplasmic
pattern  when  applied  to  certain  tumor  tissues.  the
preliminary  results  of  the  mab’s  biological  activity
showed  that  the  mab  could  effectively  inhibit  the
function of b7-H4 in the inhibition of t cell, while
promoting the growth of t cells and the secretion of
Interleukin-2 (Il-2), Interleukin-4 (Il-4), Interleukin-
10 (Il-10) and Interferon-ʳ (Ifn-ʳ). 
Conclusion: this mab will be a valuable tool for the
further investigation of b7-H4 function.
Key words: b7-H4; monoclonal antibody; immunologic
techniques; biological activity
Abbreviations: mab:  monoclonal  antibody;  ElISa:
Enzyme  linked  immunosorbent  assay;  IP:  Immuno-
precipitation; IHc: Immunohistochemical; Il-2: Inter-
leukin-2;  Il-4:  Interleukin-4;  Il-10:  Interleukin-10;
Ifn-ʳ:  Interferon-ʳ;  Rt-PcR:  reverse  transcription
polymerase chain reaction; HRP: horseradish peroxi-
dase;  fItc:  fluorescein  isothiocyanate;  oD:  optical
density.
IntRoDUctIon
the b7 family transmits both costimulatory and coin-
hibitory signals to t cells, thus controlling t cell-medi-
ated  immune  responses  and  tolerance.  b7-H4  (also
known  as  b7S1  and  b7x)  is  a  recently  discovered
member of the b7 family [1-2], and delivers a co-in-
hibitory  signal  that  down-regulates  t  cell  activation,
thereby preventing t cell proliferation, cytokine secre-
tion, and the development of cytotoxicity [1,3-4]. In
vitro experiments have shown that b7-H4 inhibits t
cell activation by down-regulating Il-2 production and
arresting the cell cycles of both cD4+ and cD8+ t
cells. In vivo experiments also support the assamption
that b7-H4 functions as an inhibitor to t cell-mediat-
ed immunity [1, 3-4].
b7-H4 plays an important role in the immune re-
sponse mediated by tumors. b7-H4 mRna transcripts
are detected extensively in the spleen, lung, thymus,
and other normal tissues; however, the protein is not
detectable in these tissues [1]. In contrast, an increas-
ing  number  of  studies  using  human  tumor  samples
have revealed that b7-H4 is overexpressed in various
tumors, including breast [5-6], ovarian [5, 7], renal [8],
prostate [9], and non-small cell lung cancers [10], and
that b7-H4 expression, as assessed using Rt-PcR and
IHc, is associated with disease progression. In addi-
tion, b7-H4 is expressed in tumor-associated suppres-
sive macrophages [11] and the serum level of soluble
b7-H4 is elevated in patients with renal cell carcinoma
and ovarian cancer [12-13]. Previous studies [5-6, 14]
have shown that the high expression of b7-H4 protein
in breast cancer decreases the number of tumor-infil-
trating lymphocytes and prevents tumor cell apoptosis. 
therefore, the b7-H4 protein is a negative regulator
of the antitumor immune response and may play an
important role in promoting tumor growth. to eluci-
date the functional and structural properties of b7-
H4, several different epitope-specific antisera against
b7-H4 have been raised in rabbits or goats. However,
there is little mab available that can be used for IHc
or other analyses. In the present study, we developed a
new mab against the extracellular domain of b7-H4.
this  development  had  great  utility  for  immunoblot-
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2. Yao_Umbruchvorlage  12.07.11  11:30  Seite 295ting,  indirect  immunofluorescence  staining,  IP,  flow
cytometry, and IHc staining. and it also had inhibitive
biological function to b7-H4. accordingly, this mono-
clonal antibody will provide a powerful tool for the
further investigation of b7-H4 function.
MatERIalS anD MEtHoDS
PRoDUctIon of antI-b7-H4 Monoclonal antIboDy
living  3t3-mb7-H4  cells  (5ￗ106),  which  were  pre-
pared as described previously [15], were used as im-
munogens to immunize 6 balb/c mice (Shanghai lab-
oratory animal center, chinese academy of Sciences)
one  injection  biweekly  (every  2  weeks)  repeated  4
times. the 2 mice with the highest antibody titer as de-
termined  by  ElISa  were  boosted  intraperitoneally
with 3t3-mb7-H4 cells 3 days before cell fusion. Peri-
toneal macrophages from normal balb/c mice used as
feeder layer cells were prepared 1 day prior to fusion.
Spleen cells from immunized animals were fused with
Sp2/0  myeloma  cells  (atcc,  va,  USa)  [16].  More
than 100 independent hybridomas were obtained from
2  fusions.  Pooled  culture  fluids  from  individual  hy-
bridoma cultures were screened for their reactivity with
the lysates of 3t3-mb7-H4 cells using direct ElISa
and by IP analysis. lysates of 3t3 cells (atcc) not
transfected with b7-H4 were used as a control [17]. a
positive hybridoma line of 3E8 was established by lim-
iting  dilution.  Isotypes  of  the  mabs  produced  were
identified  using  a  mouse  monoclonal  isotyping  kit
(abD Serotec, nc, USa). further, the hybridoma cells
were injected intraperitoneally into a balb/c mouse to
obtain  ascites  containing  high  concentrations  of  the
mab. the mab was purified from mouse ascites using
a protein l Ultralink column (Pierce, Il, USa), and
then stored at a concentration of 1.5 mg/ml.
EnzyME lInKED IMMUnoSoRbEnt aSSay
3t3-mb7-H4 or 3t3 cells (1 ￗ 106) were lysed in 200
ﾵl cell lysis buffer (cell Signaling technology, Ma,
USa) for 30 min at 4ﾰc. the insoluble material was
then  removed  by  centrifugation  at  8000  ￗ  g  for  10
min. the concentration of protein in the lysate was
determined using a bca protein assay kit (Pierce) with
bSa as the standard.
the  lysate  of  3t3-mb7-H4  cells,  diluted  to  10
ﾵg/ml in 0.01 M coating solution concentrate (KPl
company,  Maryland,  USa),  was  coated  onto  high-
binding polystyrene plates (corning life Sciences, Ma,
USa)  at  100  ﾵl  per  well,  and  incubated  at  4ﾰc
overnight. the lysate of 3t3 cells not transfected with
b7-H4 was used as a control. the wells were subse-
quently washed 5 times with PbS-tween buffer (0.05%
tween 20 in PbS). the coated wells were blocked with
200 ﾵl of 3% bSa for 2 h at room temperature and
then incubated with 100 ﾵl culture supernatant of hy-
bridoma cells or different dilutions of the mab against
b7-H4. after incubation for 1 h at room temperature,
the wells were thoroughly washed, and then incubated
with  100  ﾵl  horseradish  peroxidase-conjugated  goat
anti-mouse  IgM  (dilution  1:5000;  Santa  cruz,  ca,
USa) for 1 h at room temperature. the plates were de-
veloped using tetramethylbenzidine substrate solution
(KPl company) for 10~20 min at room temperature.
color development was stopped with 2 M H2So4 and
the absorbance was measured at 450 nm using a Model
680 microplate reader (bio-Rad, ca, USa).
WEStERn blottIng analySIS
cell  lysate  preparation  and  western  blotting  analysis
were  performed  according  to  previously  described
procedures. In brief, cell lysates were denatured for 10
min at 95ﾰc with SDS-PagE sample loading buffer,
electrophoresed on 10% SDS-PagE gels, and trans-
ferred  to  polyvinylidene  difluoride  membranes.  the
membranes  were  blocked  with  5%  nonfat  milk  in
tbSt [20 mM tris-Hcl (pH 7.5), 150 mM nacl, and
0.05% (v/v) tween 20 and incubated with 3E8 mabs
or  goat  anti-b7-H4  polyclonal  antibody  (R&D  Sys-
tems, Mn, USa) for 2 h at room temperature. after
thorough washing, the blots were incubated with HRP
conjugated  goat  anti-mouse  IgM  antibodies  (Santa
cruz)  or  rabbit  anti-goat  Igg  antibodies  (Santa
cruz).the reaction was developed using Ecl reagents
(amersham, nJ, USa) and analyzed using a versaDoc
MP5000 imaging system (bio-Rad).
IP analySIS
b7-H4 was immunoprecipitated from the 3t3-mb7-
H4  or  3t3  cells  lysates.  Individual  samples  (350  ﾵg
protein/sample) were immunoprecipitated using 3E8
mab (2 ﾵg/sample) coupled to protein l-Sepharose
beads. the purified recombinant b7-H4 protein [18]
immunoprecipitated with normal mouse IgM was used
as an antibody control [16]. Western blotting was car-
ried out using goat anti-b7-H4 polyclonal antibody as
the primary antibody, followed by rabbit anti-goat Igg
antibody coupled with HRP. the reaction was devel-
oped as described above.
floW cytoMEtRy analySIS
In order to analyze the specificity of antibody,  leu  -
kemic cells such as U937, tHP-1, Hl60, and MM1R
cells (atcc) were used in this study. Each of cells (2
ￗ 106) was incubated with 3E8 mab or goat anti-b7-
H4 polyclonal antibody for 30 min at 4ﾰc. the nor-
mal mouse IgM was used as an antibody control. cells
were  washed  and  resuspended  in  a  goat  anti-mouse
IgM coupled with fItc or donkey anti-goat Igg cou-
pled with fItc (Jackson ImmunoResearch laborato-
ries, Pa, USa) for 30 min at 4ﾰc. finally, cells were
washed twice and samples were analyzed using a flow
cytometer (facScan, ca, USa). 
IMMUnoHIStocHEMIcal StaInIng
tissue  microarrays  were  obtained  from  chaoying
biotechnology  co.,  ltD  (Shanxi,  china)  for  IHc
staining.  tumor  samples  included  those  from  the
breast, uterus, and ovary. clinical and pathological in-
formation for individual cancer samples was provided
by the array manufacturers (for details see www.cybr-
di.cn). IHc staining was carried out using 3E8 mab as
the primary antibody followed by reagents from the
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IgM was used as an antibody control. Staining intensi-
ty (0 to 3, least intense to most intense) and the pro-
portion  of  stained  cells  (0  to  4,  no  cells  stained  to
more than 70% cells stained) were semi-quantitatively
determined as previously described [19]. a combined
score of ≥2 and ≥6 was considered to indicate posi-
tive  expression  and  overexpression,  respectively.  all
slides  were  scored  by  2  observers  blinded  to  the
pathology and clinical features.
SPlEEn cEll gRoWtH DEtERMInED by MtS 
Spleen cells from normal balb/c mouse (2ￗ105 cells
per well) were seeded in triplicate in a 96-well plate
which was coated with anti-mouse cD3 mab (R&D
Systems). then, the cells were incubated with the puri-
fied recombinant b7-H4 protein [18] (2ug/ml), 3E8
mab (1 ug/ml, 2 ug/ml, and 5 ug/ml), or their admix-
ture which was premixed for 30min. normal mouse
IgM (5 ug/ml) was used as an antibody control. after
incubating the wells for 72 hours at 37ﾰc, the wells
were added with celltiter 96ﾮ aQueous one Solution
cell Proliferation assay (MtS) (Promega, WI, USa).
after incubating the wells for 4 hours at 37ﾰc, the
oD  of  each  well  was  measured  using  a  Model  680 
microplate reader at a wavelength of 490nm. 
cytoKInES DEtERMInED by ElISa
While in cytokines secretion assay, spleen cells were
treated as above. the cell culture supernatant was col-
lected respectively after incubating the wells for 48 or
72 hours at 37ﾰc. the expression of Il-2, Il-4, Il-10
in  48h  supernatant,  and  Ifn-ʳ in  72h  supernatant
were  determined  with  mouse  cytokine  ElISa  kit
(ebioscience, ca, USa), and was denoted by optical
density at 450nm.
StatIStIcal analySIS
all experiments were performed in triplicate. the data
were analyzed using SPSS 11.0 software, and P < 0.05
was considered to indicate a significant difference.
RESUltS
ISotyPE of tHE MoUSE Monoclonal antIboDy
agaInSt b7-H4
the 3E8 hybridomas that reacted selectively with b7-
H4 in all assays were further evaluated. the isotype of
the 3E8 mab, determined using a mouse monoclonal
isotyping  kit  (abD  Serotec),  was  an  IgM  with  a  ʺ
chain  (fig.  1).  Immunofluorescence  analysis  con-
firmed that 3E8 binds to the extracellular sequences of
b7-H4.  Species  cross-reactivity  studies  showed  that
3E8 was specific to the human and mouse b7-H4 pro-
teins (data not shown).
cHaRactERIzatIon of tHE 3E8 Mab SPEcIfIc
to b7-H4
ElISa analysis revealed that compared with the con-
trol,  the  titer  of  3E8  was  high,  as  b7-H4  was  de-
tectable  at  a  dilution  of  1:20000  (fig.  2).  the  im-
munoreactivity of 3E8 mab with the lysate of 3t3-
mb7-H4 cells is shown in figure 3a. Mature b7-H4 
is  a  50-  to  80-kDa  glycosylated  molecule  with  a 
28-kDa  protein  core  [5].  the  3E8  mab  specifically 
recognized protein bands of 28 and 57 kDa. the goat
anti-b7-H4  polyclonal  antibody  also  reacted  with 
both  proteins  in  the  same  experiment  (fig.  3b)  as
controls, and similarly sized proteins were detected.
ElISa  and  western  blotting  revealed  that  3E8  can
specifically  recognize  recombinant  b7-H4  in  mam-
malian cells.
tHE 3E8 Mab IMMUnoPREcIPItatES b7-H4 fRoM
cEll lySatES
next we used IP to determine the ability of 3E8 mab
to  recognize  b7-H4  in  its  native  state.  cell  extracts
were immunoprecipitated with the 3E8 mab and ana-
lyzed  by  immunoblotting  using  a  goat  anti-b7-H4
polyclonal  antibody.  b7-H4  was  selectively  immuno-
precipitated  from  3t3-mb7-H4  cell  lysates  that  ex-
pressed  b7-H4  (fig.  3c).  IP  of  lysates  with  mouse
normal  IgM  did  not  result  in  detection  of  protein
species. no corresponding band was visualized when
the 3E8 mab was used to immunoprecipitate lysates
of normal 3t3 cells. therefore, the 3E8 mab specifi-
cally recognizes native b7-H4.
floW cytoMEtRy analySIS of b7-H4 EXPRESSIon
In lEUKEMIc cEllS
We assayed the human lymphoid hematopoietic tumor
cell lines U937, tHP-1, Hl60, and MM1R for expres-
sion of b7-H4 using flow cytometry. 3E8 mab and
goat anti-b7-H4 polyclonal antibody (used as a posi-
tive control) were used as probes to detect significant
increases  in  fluorescence  intensity  in  comparison  to
cells incubated with PbS (fig. 4). the binding efficien-
cies  of  U937,  tHP-1,  Hl60,  and  MM1R  cells  with
3E8 mab were 98.4%, 88.4%, 72.2%, and 12.7%, re-
spectively, whereas those with goat anti-mb7-H4 anti-
body were 98.9%, 91.0%, 84.6%, and 30.8%, respec-
tively.  no  reactivity  was  detectable  in  the  normal
mouse IgM group (≤0.5%). 
aSSay of b7-H4 EXPRESSIon by
IMMUnoHIStocHEMIcal StaInIng
three types of normal tissue and their corresponding
cancerous tissues with case numbers from 22 to 30 in
the tissue microarrays were subjected to IHc staining.
Scores ≥6 were considered to indicate overexpression.
In general, b7-H4 was stained with a diffuse pattern
either in the membrane or in the cytoplasm of cells.
table 2 summarizes the results of these studies. Im-
munoreactive b7-H4 was detected in different types of
normal  tissue  and  their  corresponding  cancer  cells
with different expression patterns and intensities (fig.
5).  Whereas  most  tissues  expressed  b7-H4  to  some
degree, samples with scores ≤2 were mostly observed
in normal tissue with a predominantly apical membra-
nous staining. overexpression of b7-H4 (scores ≥6.0)
was found only in tumor tissues. 
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Fig. 1. the isotype of  mouse
monoclonal antibody against b7-
H4.  – the  isotype  of  the  3E8
mab, determined using a mouse
monoclonal isotyping kit, was an
IgM with a ʺ chain.
Fig.  4. flow  cytometry
analysis with 3E8 mab. –
U937,  tHP-1,  Hl60,  and
MM1R cells (2 ￗ 106 cells
per  sample  in  PbS)  were
incubated  with  3E8  mab
or  goat  anti-b7-H4  poly-
clonal antibody for 30 min
at  4ﾰc.  normal  mouse
IgM  was  used  as  an  anti-
body  control.  cells  were
washed and resuspended in
a  solution  of  goat  anti-
mouse  IgM  coupled  with
fItc  or  donkey  anti-goat
Igg  coupled  with  fItc.
finally,  cells  were  washed
twice and samples were an-
alyzed  using  a  facScan
flow cytometer. 
Fig. 2. ElISa analysis of anti-b7-H4 mab. – the lysate of
3t3-mb7-H4 cells, diluted to 10 ﾵg/ml in 0.01 M coating so-
lution concentrate, was coated onto high-binding polystyrene
plates at 100 ﾵl per well, and incubated at 4ﾰc overnight. the
lysate of 3t3 cells not transfected with b7-H4 was used as a
control. the titer of 3E8 (at an original concentration of 1.5
mg/ml) was determined by ElISa and read at a450. 
Fig. 3. IP and western blotting analysis with 3E8 mab. – a: Western
blotting was carried out for b7-H4 from lysates of 3t3-mb7-H4 or 3t3
cells using 3E8 mab, followed by goat anti-mouse IgM antibody cou-
pled with HRP. b: Western blotting was carried out for b7-H4 from
lysates of 3t3-mb7-H4 or 3t3 cells using goat anti-b7-H4 polyclonal
antibody, followed by rabbit anti-goat Igg antibody coupled with HRP.
there were protein bands of 28 and 57 kDa in a and b. c: b7-H4 was
immunoprecipitated  from  lysates  of  3t3-mb7-H4  or  3t3  cells  using
3E8 mab (2 ﾵg/sample). Western blotting was carried out for b7-H4 using goat anti-b7-H4 polyclonal antibody, followed by
rabbit anti-goat Igg antibody coupled with HRP. normal mouse IgM was used as an antibody control. lane 1: lysate from nor-
mal 3t3 cells; lane 2: lysate from 3t3-mb7-H4 cells; lane 3: b7-H4 unrelated antibody control.
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b7-H4 can preven t cell proliferation, cytokine secre-
tion [1, 3-4]. In order to test the anti or activation ef-
fect of 3E8 on b7-H4, we analysed the normal mouse
spleen  cell  growth  and  cytokines  secretion  while 
cultured with or without b7-H4 or 3E8 (fig. 6). the
number  of  living  cells  and  the  expression  levels  of
Il-2,  Il-4,  Il-10,  and  Ifn-ʳ which  were  cultured
with the admixture of 3E8 and b7-H4 was increased
in a 3E8-concentration-dependent manner compared
with  living  cells  cultured  with  only  b7-H4.  and 
there  was  a  significant  difference  while  3E8  was  5
ug/ml. 
DIScUSSIon
the structure of b7-H4 as a gPI-linked molecule dis-
tinguishes it from other b7 family members. the 90%
amino acid identity between mouse and human b7-H4
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A Breast Uterus Ovary
Normal
Tumor
Tumor
x 200
x 400
B
Normal Tumor
Tissues Case No. No of positive Total Case No. No of positive Total
Breast 36 18 1,23 ± 0.78 43 39 6.43 ± 0.32**
Uterus 33 19 1.68 ± 0.38 56 52 6.28 ± 0.76**
Ovary 35 17 1.43 ± 0.34 48 45 6.53 ± 0.59**
**: vs normal tissue, P<0.01
Fig. 5. Expression of b7-H4 in normal tissues and corresponding cancer samples from breast, uterus, and ovary. – Human nor-
mal and cancerous samples in tissue arrays were subjected to IHc staining using mab 3E8. the reactions were visualized using
reagents from a DaKo Envision System kit. normal mouse IgM was used as an antibody control (data not shown). Samples
were photographed and staining intensity (0 to 3, least intense to most intense) and the proportion of stained cells (0 to 4, no
cells stained to more than 70% cells stained) were semi-quantitatively determined. a combined score of ≥6 was considered to
indicate overexpression. 
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tion. thus, in this study, we established a 3t3-mb7-
H4 cell line expressing extrinsic mb7-H4 on the cell
membrane, and used this as an immunogen to immu-
nize balb/c mice in order to obtain mabs specific to
the  human  and  mouse  homologous  fragments.  the
3E8 mab, an IgM with a ʺ chain, could specifically
recognize  the  extracellular  domain  of  b7-H4  with
ElISa, IP, and western blot analysis. 
flow cytometry is a rapid, quantitative, multipara-
meter cellular analysis based on the measurement of
visible  and  fluorescent  light  emission.  We  used  3E8
mab for further characterization of b7-H4 based on
the  strong  signals  detected  by  immunofluorescence.
Previous studies have shown that expression of b7-
H4 was detected in some human tumor tissues and
cells [15]. We assayed the human lymphoid hematopoi-
etic tumor cell lines for expression of b7-H4 using
flow  cytometry.  the  results  demonstrated  that  the
mab  exhibits  excellent  reactivity  when  applied  to
leukemic cells. It indicated that the 3E8 mab is effec-
tive for detecting b7-H4 using flow cytometry, and the
positive tendency was consistent with the goat anti-
b7-H4 polyclonal antibody. It has been reported that
b7-H4 is constitutively expressed on some leukemic
cells derived from b-cell lymphoma cells [20]. there-
fore, aberrant b7-H4 expression may provide a theo-
retical basis for the clinical detection and diagnosis of
leukemia. Many studies have shown that monoclonal
antibodies can be used for targeted therapy in clinical
disease [21]. thus, it may be possible to develop 3E8
mab as a therapeutic monoclonal antibody for clinical
therapy.
It is reported that b7-H4 was overexpressed in tu-
mor tissues from the breast [6], ovary [22], and uterus
[23]. In order to test whether the 3E8 mab could be
used in immunohistochemistry, we determined the ex-
pression of b7-H4 in tumor tissues from the breast,
ovary, and uterus. the levels of b7-H4 expressed in
various types of cancer samples were evaluated in a
standardized and semi-quantitative manner using the
3E8 mab. Samples with scores ≤2 were mostly ob-
served in normal tissue with a predominantly apical
membranous  staining.  overexpression  of  b7-H4
(scores ≥6.0) was found only in tumor tissues with a
predominantly  diffuse  plasmalemmal  or  cytoplasmic
pattern.  these  results  are  consistent  with  previous
studies [5-7, 12-13]. thus, the 3E8 mab can detect the
expression of b7-H4 using IHc staining. the identifi-
cation of cancers with high rates of b7-H4 overex-
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Fig. 6. Spleen cell growth and cytokines se-
cretion assays. – a: Spleen cell growth deter-
mined  by  MtS.  Spleen  cells  from  normal
balb/c mouse (2ￗ105 cells per well) were
seeded in triplicate in a 96-well plate which
was  coated  with  anti-mouse  cD3  mab.
then, the cells were incubated with the puri-
fied recombinant b7-H4 protein, 3E8 mab,
or their admixture which was premixed for
30min. normal mouse IgM was used as an
antibody control. after incubating the wells
for 72 hours at 37ﾰc, the wells were added
with MtS. after incubating the wells for 4
hours  at  37ﾰc,  the  oD  of  each  well  was
measured  using  a  Model  680  microplate
reader at a wavelength of 490nm. the num-
bers  of  living  cells  were  presented  by
oD490. b: cytokines secretion determined
by  ElISa.  Spleen  cells  were  treated  as
above. the cell culture supernatant was col-
lected respectively after incubating the wells
for 48 or 72 hours at 37ﾰc. the expression
of Il-2, Il-4, Il-10 in 48h supernatant, and
Ifn-ʳ in 72h supernatant were determined
with mouse cytokine ElISa kit. the expres-
sion levels of cytokines were presented by
oD450. *: vs lane 3 and lane 5, P <0.05.
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pathogenic potential of b7-H4 in tumor development
and malignant progression. the aberrant b7-H4 ex-
pression and an mab specific to b7-H4 may provide
not only a new insight into the mechanisms of tumor
occurrence and development but also a new method
for  the  prevention  and  treatment  of  tumors  [20-21,
24-25].
b7-H4 can inhibit the t cell proliferation and cy-
tokines secretion such as Il-2, Il-4, Il-10, and Ifn-ʳ
[1, 3-4]. the presence of recombinant b7-H4 at 0.5-3
ﾵg/ml  inhibited  the  anti-cD3-induced  proliferation
of t cells by 40-60 % (details seen the manual of b7-
H4 in R&D system). So the concentration of b7-H4
in  spleen  cell  growth  and  cytokines  secretion  assays
was 2 ﾵg/ml. and b7-H4 could inhibit the anti-cD3-
induced  proliferation  and  cytokines  secretion  of
spleen  cells  which  were  cultured  with  only  b7-H4 
(fig. 6). 
antibodies  can  specifically  bind  to  its  ligand  and
lead  to  target  cell  lysis  or  blocking  the  pathological
process. So the development of the antibodies in par-
ticular  humanized  antibody  drug  plays  an  important
role in clinical therapy of human malignant and other
autoimmune diseases [26-27]. In this study, 3E8 mab
can effectively stimulate t cell proliferation, and in-
duce of Il-2, Il-4, Il-10, and Ifn-ʳ production, sug-
gesting that 3E8 mab can block b7-H4 binding to its
receptor,  which  closed  down-regulation  signal  trans-
duction of b7-H4 to t cell, and enhanced t cell reac-
tivity to various antigens. 3E8 mab as an inhibitor of
b7-H4-mediated negative regulation of t cell activa-
tion, can activate the immune response. but the mech-
anism is still being researched. b7-H4 and anti-b7-H4
mab as an important factor of t cell function can
play  specific  therapeutic  effects  of  disease  which  is
high efficacy, through the intervention of immune mi-
croenvironment. and thus we can open up a new way
of gene therapy. but at the same time, we should also
note  the  potential  impact  of  long-term  application,
such as b7-H4 mab over-blocking signal of b7-H4
and its receptor leading to autoimmune diseases.
In summary, we generated specific mabs directed
against b7-H4. the mab 3E8 exhibited the best per-
formance  in  a  variety  of  assays,  including  im-
munoblotting, IP, flow cytometry, and IHc staining.
and the mab could effectively inhibit the function of
b7-H4 in the inhibition of t cell, while promoting the
growth  of  t  cells  and  the  secretion  of  Il-2,  Il-4, 
Il-10 and Ifn-ʳ. this specific mab may provide an
ideal tool for further investigation of the function of
b7-H4.
Acknowledgement: this  study  was  supported  by  a  grant
#30972777  (to  HPy)  from  the  national  natural  Science
foundation of china.
REfEREncES
1. Sica gl, choi IH, zhu g, tamada K, Wang SD, tamura
H, chapoval aI, flies Db, bajorath J, chen l. b7-H4, a
molecule of the b7 family, negatively regulates t cell im-
munity. Immunity. 2003; 18: 849-861
2. chen l. co-inhibitory molecules of the b7- cD28 family
in the control of t cell immunity. nature Rev Immunol.
2004; 4: 336-347
3.  b7x: a widely expressed b7 family member that inhibits t
cell  activation.  Proc  natl  acad  Sci  USa.  2003;  100:
10388–10392
4. Prasad DvR, Richards S, Mai XM, Dong c. b7S1, a nov-
el b7 family member that negatively regulates t cell acti-
vation. Immunity. 2003; 18: 863-873
5. Salceda  S,  tang  t,  Kmet  M,  Munteanu  a,  ghosh  M,
Macina  R,  liu  W,  Pilkington  g,  Papkoff  J.  the  im-
munomodulatory  protein  b7-H4  is  overexpressed  in
breast and ovarian cancers and promotes epithelial cell
transformation. Exp cell Res. 2005; 306: 128-141
6. tringler b, zhuo S, Pilkington g, torkko Kc, Singh M,
lucia MS, Heinz DE, Papkoff J, Shroyer KR. b7-h4 is
highly expressed in ductal and lobular breast cancer. clin
cancer Res. 2005; 11: 1842- 1848
7. choi IH, zhu g, Sica gl, Strome SE, cheville Jc, lau
JS, zhu y, flies Db, tamada K, chen l. genomic orga-
nization and expression analysis of b7-H4, an immune in-
hibitory molecule of the b7 family. J Immunol. 2003; 171:
4650- 4654
8. Krambeck  aE,  thompson  RH,  Dong  H,  lohse  cM,
Park ES, Kuntz SM, leibovich bc, blute Ml, cheville
Jc, Kwon ED. b7-H4 expression in renal cell carcinoma
and tumor vasculature: associations with cancer progres-
sion and survival. Proc nati acad Sci USa. 2006; 103:
10391- 10396
9. zang  X,  thompson  RH,  al-ahmadie  Ha,  Serio  aM,
Reuter vE, Eastham Ja, Scardino Pt, Sharma P, allison
JP.  b7-H3  and  b7x  are  highly  expressed  in  human
prostate  cancer  and  associated  with  disease  spread  and
poor  outcome.  Proc  natl  acad  Sci  USa.  2007;  104:
19458-19463
10. Sun y, Wang y, zhao J, gu M, giscombe R, lefvert aK,
Wang X. b7-H3 and b7-H4 expression in non-small-cell
lung cancer. lung cancer. 2006; 53: 143- 151
11. Kryczek I, zou l, Rodriguez P, zhu g, Wei S, Mottram
P, brumlik M, cheng P, curiel t, Myers l, lackner a,
alvarez X, ochoa a, chen l, zou W. b7-H4 expression
identifies a novel suppressive macrophage population in
human ovarian carcinoma. J Exp Med. 2006; 203: 871-881
12. Simon  I,  zhuo  S,  corral  l,  Diamandis  EP,  Sarno  MJ,
Wolfert  Rl,  Kim  nW.  b7-H4  Is  a  novel  Membrane-
bound Protein and a candidate Serum and tissue bio-
marker for ovarian cancer. cancer Res. 2006; 66: 1570-
1575
13. thompson  RH,  zang  X,  lohse  cM,  leibovich  bc,
Slovin Sf, Reuter vE, cheville Jc, blute Ml, Russo P,
Kwon ED, allison JP. Serum-soluble b7x is elevated in
renal cell carcinoma patients and is associated with ad-
vanced stage. cancer Res. 2008; 68: 6054-6058
14. Mugler  Kc,  Singh  M,  tringler  b,  torkko  Kc,  liu  W,
Papkoff J, Shroyer KR. b7-h4 expression in a range of
breast  pathology:  correlation  with  tumor  t-cell  infiltra-
tion. appl Immunohistochem Mol Morphol. 2007; 15(4):
363-370
15. Qian y, Shen l, cheng lf, Wu zg, yao HP. b7-H4 ex-
pression in various tumors determined using a novel de-
veloped  monoclonal  antibody.  clin  Exp  Med.  2010;
[printed in head]
16. yao HP, luo yl, feng l, cheng lf, lu y, li W, Wang
MH. agonistic monoclonal antibodies potentiate tumori-
genic  and  invasive  activities  of  splicing  variant  of  the
Ron receptor tyrosine kinase. cancer biol ther. 2006; 5:
1179-1186
17. nelson Pn, Reynolds gM, Waldron EE, Ward E, gi-
annopoulos K, Murray Pg. Monoclonal antibodies. Mol-
ecular Pathology. 2000; 53 : 111-117
18. Qian  y,  yao  HP,  cheng  lf,  Shen  l,  gu  lJ,  tao  l,
zhang lH. Expression and identification of recombinant
mouse gene b7-H4. Journal of zhejiang University (med-
ical sciences). 2009; 38: 117-124
EURoPEan JoURnal of MEDIcal RESEaRcH July 25, 2011 301
2. Yao_Umbruchvorlage  12.07.11  11:30  Seite 30119. allred Dc, Harvey JM, berardo M, clark gM. Prognostic
and predictive factors in breast cancer by immunohisto-
chemical analysis. Mod Pathol. 1998; 11: 155-168
20. Park gb, Song H, Kim yS, Sung M, Ryu JW, lee HK,
cho DH, Kim D, lee WJ, Hur Dy. cell cycle arrest in-
duced by engagement of b7-H4 on Epstein-barr virus-
positive b-cell lymphoma cell lines. Immunology. 2009;
128(3): 360-368
21. guin S, yao HP, Wang MH. Ron receptor tyrosine ki-
nase as a target for delivery of chemodrugs by antibody
directed pathway for cancer cell cytotoxicity. Mol Pharm.
2010; 7(2): 386-397
22. tringler b, liu W, corral l, torkko Kc, Enomoto t,
Davidson  S,  lucia  MS,  Heinz  DE,  Papkoff  J,  Shroyer
KR. b7-H4 overexpression in ovarian tumors. gynecol
oncol. 2006; 100: 44- 52
23. Miyatake  t,  tringler  b,  liu  W,  liu  SH,  Papkoff  J,
Enomoto t, torkko Kc, Dehn Dl, Swisher a, Shroyer
KR.  b7-H4  (DD-o110)  is  overexpressed  in  high  risk
uterine endometrioid adenocarcinomas and inversely cor-
related  with  tumor  t-cell  infiltration.  gynecol  oncol.
2007; 106: 119-127
24. cheng l, Jiang J, gao R, Wei S, nan f, li S, Kong b. b7-
H4 expression promotes tumorigenesis in ovarian cancer.
Int J gynecol cancer. 2009; 19: 1481-1486
25. Jiang J, zhu y, Wu c, Shen y, Wei W, chen l, zheng X,
Sun J, lu b, zhang X. tumor expression of b7-H4 pre-
dicts poor survival of patients suffering from gastric can-
cer. cancer Immunol Immunother. 2010; 59(11): 1707-
1714
26. azzoni c, bottarelli l, cecchini S, lagrasta c, Pizzi S,
D'adda t, tamburini E, Rindi g, bordi c. Involvement
of HER-2/neu and metastasis-related proteins in the de-
velopment  of  ileal  neuroendocrine  tumors.  virchows
arch. 2011; [Epub ahead of print]
27. zynek-litwin M, Kuzniar J, nocen-Rychlewska b, Kusz-
tal  M,  Klinger  M.  an  inconspicuous  insect  bite  as  the
cause of sepsis in a patient treated with infliximab due to
rheumatoid arthritis. adv Med Sci. 2011; [Epub ahead of
print]
Received: May 2, 2011 / Accepted: May 16, 2011
Address for correspondence:
Hang-Ping yao, associate Professor
State Key laboratory for Diagnosis and treatment of 
Infectious Diseases
the first affiliated Hospital
zhejiang University School of Medicine
79 Qingchun Road
Hangzhou 310003
china
tel: +86-571-87236580
fax: +86-571-87236582
E-mail: yaohangping@zju.edu.cn
EURoPEan JoURnal of MEDIcal RESEaRcH 302 July 25, 2011
2. Yao_Umbruchvorlage  12.07.11  11:30  Seite 302